FDA Approved: DUTASTERIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for dutasteride from Aurobindo Pharma Limited under ANDA 202660.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)

Snippet

SUPPL AP for DUTASTERIDE (DUTASTERIDE)